Once versus twice daily mesalazine to induce remission in paediatric ulcerative colitis: an investigator-initiated randomised controlled trial

被引：0
|
作者：
Turner, D. [1 ]
Yerushalmi, B. [2 ]
Kori, M. [3 ]
Broide, E. [4 ]
Mozer-Glassberg, Y. [5 ]
Shaoul, R. [6 ]
Kolho, K-L [7 ]
Shteyer, E. [8 ]
Shamaly, H. [9 ]
Ledder, O. [10 ]
Cohen, S. [11 ]
Peleg, S. [12 ]
On, A. [13 ]
Levine, A. [14 ]
机构：
[1] Shaare Zedek Med Ctr, Inst Paediat Gastroenterol, Jerusalem, Israel
[2] Soroka Med Ctr, IL-84101 Beer Sheva, Israel
[3] Kaplan Hosp, IL-76100 Rehovot, Israel
[4] Asaff Harofeh, Tel Aviv, Israel
[5] Schneiders Children Hosp, Petah Tiqwa, Israel
[6] Rambam Med Ctr, Haifa, Israel
[7] Univ Helsinki, Childrens Hosp, Helsinki, Finland
[8] Hadassah Med Ctr, Kiryat Haddasah, IL-91120 Jerusalem, Israel
[9] French Hosp, Nazareth, Israel
[10] Shaare Zedek Med Ctr, Jerusalem, Israel
[11] Tel Aviv Med Ctr & Sch Med, Tel Aviv, Israel
[12] Emek Med Ctr, Afula, Israel
[13] Poria, Tiberias, Israel
[14] Wolfson Med Ctr, Holon, Israel
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P623
引用
收藏
页码：S416 / S416
页数：1
相关论文
共 50 条
  • [31] Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis:: A randomised trial
    Folwaczny, C
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2000, 38 (06): : 547 - 550
  • [32] Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis:: a randomised trial
    Rembacken, BJ
    Snelling, AM
    Hawkey, PM
    Chalmers, DM
    Axon, ATR
    LANCET, 1999, 354 (9179): : 635 - 639
  • [33] Clinical trial: once-daily mesalamine granules for maintenance of remission of ulcerative colitis - a 6-month placebo-controlled trial
    Lichtenstein, G. R.
    Gordon, G. L.
    Zakko, S.
    Murthy, U.
    Sedghi, S.
    Pruitt, R.
    Merchant, K.
    Shaw, A.
    Bortey, E.
    Forbes, W. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (08) : 990 - 999
  • [34] Results of the first paediatric randomised controlled trial of faecal microbiota transplant for ulcerative colitis
    Pai, N.
    Popov, J.
    Hill, L.
    Hartung, E.
    Grzywacz, K.
    Godin, D.
    Thabane, L.
    Lee, C.
    Khan, W.
    Surette, M.
    Moayyedi, P.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S379 - S379
  • [35] Feasibility of the first paediatric randomised controlled pilot trial of faecal microbiota transplant for ulcerative colitis
    Pai, N.
    Popov, J.
    Hartung, E.
    Hill, L.
    Grzywacz, K.
    Godin, D.
    Thabane, L.
    Lee, C.
    Surette, M.
    Moayyedi, P.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S353 - S354
  • [36] Nutritional support in hospitalised patients with diabetes and risk for malnutrition: a secondary analysis of an investigator-initiated, Swiss, randomised controlled multicentre trial
    Keller, Bettina
    Wunderle, Carla
    Tribolet, Pascal
    Stanga, Zeno
    Kaegi-Braun, Nina
    Mueller, Beat
    Schuetz, Philipp
    BMJ OPEN, 2024, 14 (08):
  • [37] Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial
    Ebata, Satoshi
    Yoshizaki, Ayumi
    Oba, Koji
    Kashiwabara, Kosuke
    Ueda, Keiko
    Uemura, Yukari
    Watadani, Takeyuki
    Fukasawa, Takemichi
    Miura, Shunsuke
    Yoshizaki-Ogawa, Asako
    Asano, Yoshihide
    Okiyama, Naoko
    Kodera, Masanari
    Hasegawa, Minoru
    Sato, Shinichi
    LANCET RHEUMATOLOGY, 2021, 3 (07): : E489 - E497
  • [38] Indication-specific feasibility assessment of a placebo-controlled randomised mesalazine withdrawal study for paediatric patients with ulcerative colitis
    Croft, N.
    Faubion, W.
    Tierens, D.
    Dewulf, J.
    Bwirire, D.
    Stefani-Hunyady, D.
    Cataldi, F.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S336 - S337
  • [39] Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis: An investigator-initiated multicenter double-blind clinical trial
    Uchiyama, Kan
    Takami, Shinichiro
    Suzuki, Hideo
    Umeki, Kiyotaka
    Mochizuki, Satoshi
    Kakinoki, Nobushige
    Iwamoto, Junichi
    Hoshino, Yoko
    Omori, Jun
    Fujimori, Shunji
    Yanaka, Akinori
    Mizokami, Yuji
    Ohkusa, Toshifumi
    PLOS ONE, 2020, 15 (11):
  • [40] Mesalazine granules 1.5 g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials
    Lichtenstein, G. R.
    Zakko, S.
    Gordon, G. L.
    Murthy, U.
    Sedghi, S.
    Pruitt, R.
    Merchant, K.
    Bortey, E.
    Forbes, W. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (02) : 126 - 134
12345